Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H O Hallander

Showing results (41-50 of 63) with videos related to

Pageof 7
Sort By:
Vaccine|March 16, 2000
Diphtheria antitoxin response to DTP vaccines used in Swedish pertussis vaccine trials, persistence and projection for timing of boosterM Tiru, H O Hallander, L Gustafsson, et al.
Antimicrobial Agents and Chemotherapy|November 1, 1982
Synergism between aminoglycosides and cephalosporins with antipseudomonal activity: interaction index and killing curve methodH O Hallander, K Dornbusch, L Gezelius, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 26, 2001
How to make sense of pertussis immunogenicity dataP Olin, H O Hallander, L Gustafsson, et al.
Scandinavian Journal of Infectious Diseases|January 1, 1977
Group B beta-hemolytic streptococci as an important cause of perinatal mortalityT Berg, H O Hallander, G Nathorst-Windahl, et al.
Lancet (London, England)|December 11, 1997
Randomised controlled trial of two-component, three-component, and five-component acellular pertussis vaccines compared with whole-cell pertussis vaccine. Ad Hoc Group for the Study of Pertussis VaccinesP Olin, F Rasmussen, L Gustafsson, et al.
Molecular and Cellular Probes|June 1, 1990
A DNA hybridization test for detection of Bordetella in nasopharyngeal specimensE Reizenstein, E Morfeldt, G Gilljam, et al.
Developments in Biological Standardization|December 17, 1998
Measuring protection; a case study of pertussis vaccines--Swedish Trial II: secondary non-randomized comparisons between two schedules of infant vaccinationP Olin, H O Hallander, L Gustafsson, et al.
The New England Journal of Medicine|February 8, 1996
A controlled trial of a two-component acellular, a five-component acellular, and a whole-cell pertussis vaccineL Gustafsson, H O Hallander, P Olin, et al.
Diagnostic Microbiology and Infectious Disease|October 1, 1993
Diagnostic evaluation of polymerase chain reaction discriminative for Bordetella pertussis, B. parapertussis, and B. bronchisepticaE Reizenstein, B Johansson, L Mardin, et al.
Medical Microbiology and Immunology|January 1, 1986
Routine use of counterimmunoelectrophoresis for the detection of pneumococcal antigen in sputumC H Ericsson, H O Hallander, A Rosen, et al.
Pageof 7

Showing results (41-50 of 63) with videos related to

Sort By:
Pageof 7
Vaccine|March 16, 2000
Diphtheria antitoxin response to DTP vaccines used in Swedish pertussis vaccine trials, persistence and projection for timing of boosterM Tiru, H O Hallander, L Gustafsson, et al.
Antimicrobial Agents and Chemotherapy|November 1, 1982
Synergism between aminoglycosides and cephalosporins with antipseudomonal activity: interaction index and killing curve methodH O Hallander, K Dornbusch, L Gezelius, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 26, 2001
How to make sense of pertussis immunogenicity dataP Olin, H O Hallander, L Gustafsson, et al.
Scandinavian Journal of Infectious Diseases|January 1, 1977
Group B beta-hemolytic streptococci as an important cause of perinatal mortalityT Berg, H O Hallander, G Nathorst-Windahl, et al.
Lancet (London, England)|December 11, 1997
Randomised controlled trial of two-component, three-component, and five-component acellular pertussis vaccines compared with whole-cell pertussis vaccine. Ad Hoc Group for the Study of Pertussis VaccinesP Olin, F Rasmussen, L Gustafsson, et al.
Molecular and Cellular Probes|June 1, 1990
A DNA hybridization test for detection of Bordetella in nasopharyngeal specimensE Reizenstein, E Morfeldt, G Gilljam, et al.
Developments in Biological Standardization|December 17, 1998
Measuring protection; a case study of pertussis vaccines--Swedish Trial II: secondary non-randomized comparisons between two schedules of infant vaccinationP Olin, H O Hallander, L Gustafsson, et al.
The New England Journal of Medicine|February 8, 1996
A controlled trial of a two-component acellular, a five-component acellular, and a whole-cell pertussis vaccineL Gustafsson, H O Hallander, P Olin, et al.
Diagnostic Microbiology and Infectious Disease|October 1, 1993
Diagnostic evaluation of polymerase chain reaction discriminative for Bordetella pertussis, B. parapertussis, and B. bronchisepticaE Reizenstein, B Johansson, L Mardin, et al.
Medical Microbiology and Immunology|January 1, 1986
Routine use of counterimmunoelectrophoresis for the detection of pneumococcal antigen in sputumC H Ericsson, H O Hallander, A Rosen, et al.
Pageof 7